Biomedical subjects

R Guidoin

Publications and source records attributed to R Guidoin.

At least 73 records · Page 4Linked to original sources

PubMed1995

Residual organic debris on processed surgical instruments.

This preliminary study describes the degree of cleanliness of three categories of surgical instruments after processing (ie, decontamination, inspection, sterilization). The three categories were reusable laparoscopic, reused disposable laparoscopic, and conventional surgical instruments. The objective of the study was to identify from visual inspection and microscopic examination residual particles, stains, or liquid on processed instruments. The investigators studied 32 instruments selected at random from a hospital's supply of processed surgical instruments. On visual inspection, 90.6% (29/32) of the instruments appeared clean. Microscopic examination with a photomicrographic system, however, revealed residual debris on 84.3% (27/32) of the instruments. The quantity of residual debris on both types of laparoscopic instruments (ie, reusable, reused disposable) was equivalent. The conventional instruments contained less residual debris than the laparoscopic instruments. Sites that contained residual debris included junctions between insulating sheaths and activating mechanisms of laparoscopic instruments and articulations and grooves of forceps. More research is needed to determine the prevalence and clinical significance of these findings.

Alberta↗

PubMed1995

Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil.

To date, no arterial substitute has been shown to be as effective as the autologous saphenous vein in peripheral revascularization procedures. In the present study, the venous allograft was evaluated as a vascular substitute in terms of patency and induction of host immune reactivity, whether used in major histocompatibility complex-incompatible, major histocompatibility complex-incompatible dogs. The immunosuppressive drug therapies were given for a period of 31 days, beginning 1 day before transplantation, and consisted of the use of cyclosporine A, mycophenolate mofetil, or a combination of both. All histoincompatible allografts were thrombosed at 4 or 8 weeks after transplantation with antibody development and cell-mediated cytotoxicity in the graft, whereas histocompatible allografts showed late stenosis without immunologic reactions directed toward donor cells. Given alone, neither cyclosporine A nor mycophenolate mofetil improved the overall patency of venous allografts; thrombosis occurred shortly after cessation of immunosuppression. Still, the cyclosporine A-mycophenolate mofetil combination therapy led to a 100% patency rate at 20 weeks after implantation and immune reactions were markedly reduced. This study shows that the fresh vein allograft is still an attractive and functional alternative to the autologous saphenous vein if the host immunologic reactions are controlled by cyclosporine A-mycophenolate mofetil immunosuppression.

Animals↗

PubMed1995

Luminal surface concentration of lipoprotein (LDL) and its effect on the wall uptake of cholesterol by canine carotid arteries.

PURPOSE: The effect of near-wall blood flow velocity and plasma filtration velocity across the arterial wall on luminal surface concentration of low-density lipoproteins (LDL) and the uptake of tritium-cholesterol were investigated. METHODS: A numeric analysis of LDL transport in steady flow, over the range of physiologically relevant flow rates, predicted a surface concentration of LDL of 4% to 16% greater than that in the bulk flow. The LDL surface concentration increased linearly with filtration velocity and inversely with wall shear rate. RESULTS: These were validated experimentally in canine carotid arteries. When the transmural pressure was increased from 100 to 200 mm Hg, the filtration velocity increased from 5.13 x 10(-6) cm/sec to 8.41 x 10(-6) cm/sec, whereas the normalized uptake rate of tritium-cholesterol increased from 3.58 x 10(-4) cm/hour to 7.36 x 10(-4) cm/hour. CONCLUSION: These results indicate that lipids accumulate at the luminal surface in areas where blood flow velocity and wall shear stress are low and where the permeability of the endothelial layer is enhanced. Moreover, the rate of lipid infiltration into the blood vessel walls is affected by the luminal surface concentration. These findings are consistent with chronic hypertension and elevated blood cholesterol concentrations being major risk factors for atherosclerosis.

Animals↗

PubMed1995

Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.

Thrombogenesis is considered the principal cause of early failure of arterial grafts. Although antithrombotic drugs are recommended, their efficiency under low blood flow conditions is still being debated. In this study, we evaluated the ability of three drugs to modify the thrombotic properties of blood and, consequently, to influence platelet and fibrin deposition on the luminal surface of polyester arterial prostheses. In dogs receiving saline (control, n = 10), heparin (100 U/kg, n = 5), aspirin (325 mg, n = 5), or prostacyclin (15 ng/kg/min, n = 5), a 30-cm, woven, loop-shaped, DeBakey arterial prosthesis was implanted as a substitute for the infrarenal aorta and exposed to reduced blood flow (50 ml/min) for 4 h. The parameters of the blood measured included activated clotting time (ACT) and platelet aggregation with collagen, determined before and after each treatment. Blood deposits were quantified using 111In labeled platelets and 125I-labeled fibrinogen. The ACT was significantly prolonged only after heparin treatment, and platelet aggregation, which was decreased by 35% (p < 0.05) after heparin treatment, was almost abolished after aspirin and prostacyclin treatments. As compared with the control group, both platelet and fibrin uptake on the luminal surface of the prostheses were reduced significantly by heparin by 87 and 37%, respectively. Despite their inhibition of platelet aggregation in vitro, aspirin and prostacyclin induced no significant change in platelet and fibrin deposition on the luminal surface of the woven polyester arterial prostheses under low blood flow conditions. Under such conditions, however, thrombin generation with subsequent platelet-fibrin deposition was prevented by use of heparin anticoagulant therapy.

Administration, Oral↗

PubMed1995

Polyvinylidene fluoride monofilament sutures: can they be used safely for long-term anastomoses in the thoracic aorta?

Polyvinylidene fluoride (PVDF) represents an attractive alternative to polypropylene as a monofilament vascular suture because of its satisfactory physicochemical properties, it ease of handling, and its good biocompatibility. However, the polymer's ability to remain mechanically and chemically stable when exposed to a mild hydrolytic environment over the long term has yet to be demonstrated. One in vitro study involved the comparison of the long-term relative resistance of PVDF and polypropylene sutures to hydrolysis for a period of 9 years. The PVDF suture showed major molecular rearrangements from the original ratio of three crystalline structures to the single beta crystalline phase. The observation of some surface oxidation and water inhibition did not significantly modify the tensile strength of the PVDF suture, which retained 92.5% of its original value. In contrast, the polypropylene sample did not undergo any recrystallization but was associated with more oxidation byproducts and more water molecules near the surface, which contributed to a 46.6% loss in initial tensile strength. An in vivo study confirmed that PVDF sutures are biocompatible and are able to maintain satisfactory biostability when used to anastomose thoracic aortic allografts for a period of 6 months in the dog. The cellular reaction of fresh allografts as well as the control autografts to PVDF sutures was minimal. In other allografts that had been preserved in a supplemented medium for 1 week prior to implantation, the PVDF sutures healed satisfactorily with the formation of neocollagen and few macrophages surrounding the monofilament. No evidence of instability at the allograft-host artery junction was observed, confirming that the PVDF sutures were able to ensure a secure anastomosis in the thoracic aorta. PVDF sutures have demonstrated superior long-term biostability in vitro and minimal tissue response in vivo. These are two essential requirements when evaluating the use of a suture for vascular surgery in general and thoracic aortic surgery in particular.

Anastomosis, Surgical↗

PubMed1995

The gelweave polyester arterial prosthesis.

OBJECTIVE: To determine the effect of the gelatin coating on the efficacy of Gelweave, a new gelatin-sealed woven polyester graft material, as an arterial prosthesis. DESIGN: In-vitro and in-vivo studies of the prosthesis. SETTING: A laboratory of experimental surgery in a university teaching institution. SUBJECTS: After in-vitro testing of the material, eight dogs were subjected to a series of in-vivo tests to evaluate the properties of Gelweave in comparison with its unsealed precursor and a commerically available collagen-coated woven polyester prosthesis. INTERVENTION: Implantation of the prosthesis as a thoracoabdominal bypass for prescheduled periods ranging from 4 hours to 6 months. MAIN OUTCOME MEASURES: Physical and chemical properties of the virgin prosthesis compared with the other two prostheses, effects of the gelatin-sealed prosthesis on healing, the hematologic characteristics of the dogs before operation and at sacrifice, microscopic studies, fibrin and platelet uptakes, prostaglandin secretion, and properties of the Gelweave grafts removed at varying periods after implantation. RESULTS: The gelatin sealant in the Gelweave prosthesis effectively reduced the water permeability of the new prototype to zero. Neither blood loss at implantation nor infection during the postimplantation period was observed. The gelatin impregnation did not cause any adverse response in the dogs and was completely lysed within 2 weeks, thus allowing encapsulation and graft healing to progress satisfactorily. After 2 weeks, the prostacyclin:thromboxane ratio was greater than 1.0, whereas the fibrin and platelet uptakes on the luminal surface of the Gelweave grafts remained low, regardless of the period of implantation. Analysis of the explanted grafts confirmed that this gelatin-sealed prototype prosthesis healed satisfactorily and no adverse biologic response occurred as a result of the gelatin coating. It maintained its biostability during 6 months in situ. CONCLUSION: The new Gelweave arterial prosthesis is ready for clinical use as a thoracic and abdominal vascular substitute.

Animals↗

PubMed1995

[Macroscopic, histologic and ultrastructural study of 89 prostheses of anterior cruciate ligament excised because of prosthesis failure].

PURPOSE OF THE STUDY: This study concerns the etiology of failed synthetic anterior cruciate ligament (ACL) prostheses, and attempts to identify the primary mechanisms that lead to their premature rupture. MATERIAL AND METHODS: A total of 89 failed and surgically excised ACL prostheses were retrieved from young and active patients (27 +/- 7 years) at various orthopaedic centres in France. Their average duration of implantation was 34 +/- 24 months. They were examined macroscopically, histologically and by scanning electron microscopy (SEM) to determine the model, the manufacturer, the surgical technique used at implantation, the extent of healing, the site of rupture, as well as the morphology of the damage fibers. RESULTS: Seventy two of these explants represented 6 different models. While all 6 were fabricated from polyester fibres, each had a different textile construction, and each were associated with a unique healing and mechanical response in vivo. SEM observations confirmed that abrasion of the textile fibres were a phenomenon common to all models, and were the primary cause of prosthesis failure. Such wear zones were particularly prevalent at the exit of the tibial tunnel and around the femoral condyle. Collagenic infiltration into the synthetic ACL was poorly organized and unpredictable. It did not increase with the duration of implantation. In fact in certain models, it appeared to have caused deterioration and fraying of the textile structure rather than serving as a reinforcing matrix around the prosthesis. DISCUSSION: A synthetic ACL prosthesis is to be preferred for patients who do not have tissue available for autologous ligamentoplasty. Yet none of the synthetic devices examined in the present study were capable of stabilizing the knee over the long term. Among the factors that influenced their failure we found that the three most common mechanisms were flat abrasion against an osseous surface, flexural and rotational fatigue of the fibres, and loss of integrity of the textile structure due to unpredictable tissue infiltration during healing. CONCLUSION: The results of the present study show that none of the current models succeed in replacing the natural ACL. Future improvements may be achieved by developing surgical procedures for implantation combined with a prosthesis made from fibres and textile structures which are more abrasion resistant and promote predictable and controlled tissue infiltration.

Adult↗

PubMed1994

Posttransplant antibodies and fresh venous allograft failure in dogs.

Small diameter arterial reconstruction is usually achieved by use of the autologous long saphenous vein. As an alternative to this blood conduit, the venous allograft has been used with some success in the past, but is likely to be the target of an immune rejection reaction from the host. This study was designed to characterize humoral immune reactions possibly involved in the outcome of venous allografts. Ten mongrel dogs received a histoincompatible femoral vein allograft and an autograft as interposition grafts to both femoral arteries. They were investigated for donor-specific antibody development using donor splenocytes and cultured vascular endothelial cells (EC). Serum samples were collected at surgery, at 2 weeks, and every month until graft occlusion occurred. All autografts were patent at retrieval except one, and all allografts underwent thrombosis. In all dogs, donor-specific IgG development was observed that appeared specifically at 4 weeks and lasted until graft occlusion was detected. All reactive sera were cytotoxic to donor EC except one, and this reactivity was completely lost after serum absorption on donor splenocytes. This latter absorption resulted in the total loss of flow cytometric reactivity against donor EC in 3 dogs, whereas a low reactivity was still present in 4 dogs. Immunoblotting analysis showed a posttransplant reactivity against various protein bands on donor EC. Absorption of the reactive serum on donor splenocytes resulted in the loss of reactivity to proteins of approximately 40, 30, and 22 kDa in most experiments. Moreover, as demonstrated by immunofluorescence on cryostat sections of explanted grafts, IgG deposition was seen mainly in the media and the adventitia of the allografts but not in autografts. These results suggest that a donor-specific antibody response directed mainly against MHC antigens might play a role in the thrombosis of histoincompatible venous allografts, thus decreasing the patency rate.

Animals↗

PubMed1994

Bursting strength evaluation. Comparison of 0-Prolene sutures and endoscopic staples in an experimental prosthetic patch repair of abdominal wall defect.

Recently, titanium staples have been designed to stabilize a small prosthetic mesh used for laparoscopic herniorrhaphy. Unlike the giant prosthesis employed by Stoppa, the small mesh must be fixed to the surrounding musculo-aponeurotic defect. The strength of these titanium staples has never been evaluated and was compared to 0-Prolene sutures. In an ex vivo study, we evaluated the maximal stress (bursting strength [BS]) a repair performed with 0-Prolene sutures or staples can bear. Bilateral abdominal-wall defects were created in 16 piglets. A Prolene mesh was fixed preperitoneally on one side of the abdomen with 0-Prolene sutures and on the other side with the Endopath EMS stapler or the Endo Hernia stapler. The mean BS of meshes attached with 0-Prolene was 1,461.7 mmHg. The mean BS of meshes fixed with Endopath EMS staples was 885.5 mmHg and that of meshes fixed with Endo Hernia staples was 665.2 mmHg. A repair with 0-Prolene sutures is stronger (P < 0.05) than one with staples (Endopath EMS or Endo Hernia). Also, repair with an Endopath EMS stapler has a significantly higher BS (P < 0.05) than one with the Endo Hernia stapler. In the second part of the study, evaluation of the longitudinal tensile strength also showed that 0-Prolene sutures are stronger (P < 0.05) than staples. Endopath EMS staples are stronger (P < 0.05) than Endo Hernia staples.

Abdominal Muscles↗

PubMed1994

Morphological, physical and chemical evaluation of the Vascugraft arterial prosthesis: comparison of a novel polyurethane device with other microporous structures.

In this study the morphology, physical properties, surface chemical characteristics and microstructure of the Vascugraft arterial prosthesis have been investigated. This is a novel microporous polyurethane device, recently developed by the company Braun-Melsungen AG in Germany for use as a small calibre arterial substitute. This comparative study included two other synthetic grafts: the Mitrathane prosthesis, a hydrophilic prototype polyetherurethane urea graft with closed internal pores, and the commercially successful expanded polytetrafluoroethylene reinforced Goretex prosthesis with an open microporous structure. The Vascugraft prosthesis contains a network of fused microfibres of varying thickness and orientation which provide open and communicating pores similar in size to those in the Goretex material. In addition, they extend from one side of the graft wall to the other. As well as having superior longitudinal and radial compliance to the reinforced Goretex device, the Vascugraft prosthesis has more than adequate bursting and suture retention strengths. Through the use of contact angle measurements, electron spectroscopy for chemical analysis, Fourier transform infrared spectroscopy, differential scanning calorimetry and molecular weight analysis by size exclusion chromatography, the surface of the Vascugraft prosthesis has been shown to be uniquely hydrophobic, as well as containing carbonate groups within an aliphatic polyesterurethane polymer. In addition, variations in micro-phase separation structure of hard and soft segment domains between different sizes and batches of product are marginal. Because of the interesting physical and chemical properties, it is recommended that in vitro biocompatibility and biostability studies be undertaken prior to using the prosthesis in animal or clinical trials.

Animals↗

PubMed1994

In vivo performance of the polyesterurethane Vascugraft prosthesis implanted as a thoraco-abdominal bypass in dogs: an exploratory study.

Among the various prototype vascular prostheses that have been developed over recent years as small vessel substitutes, the Vascugraft polyurethane device produced by Braun-Melsungen AG has a number of attractive features. As well as having high mechanical compliance similar to that of the arterial tree, it has been manufactured from a specially synthesized poly(ester urethane) with improved biostability and its microfibrous structure provides a highly porous wall with open communicating pores. With a view to evaluating the in vivo biofunctionality and biostability of this prosthesis in the dog, 10 mm diameter grafts were implanted as thoraco-abdominal bypasses for prescheduled periods of 1 months and 12 months, and their performance monitored in terms of gross morphology, histology and the measurement of the chemical and physical properties of the explanted and cleaned specimens. Both grafts were patent at retrieval. Each had a smooth and glistening flow surface without organized mural thrombi and showed the development of a thin collagenous internal capsule with the presence of endothelial-like cells. Both grafts were well encapsulated externally and revealed a small distal bend or kink which is frequently observed by any thoraco-abdominal bypass in dogs. The fresh explanted prostheses were cleaned by a new enzyme treatment which provided specimens for microscopic, mechanical and thermal analyses, as well as studies of the surface and bulk chemistry. By comparing the results from the explanted and cleaned material with those of the virgin prosthesis, we have observed some deterioration in the integrity of the microfibrous structure, some loss in mechanical performance, marginal changes in molecular weight, and an apparent microphase separation of the hard and soft segment domains at a depth of a few microns. While the biofunctionality of a 10 mm calibre device has been demonstrated, additional in vivo studies are recommended to assess the biofunctionality at different diameters and the biostability over longer periods of implantation.

Abdomen↗

PubMed1994

Quantitative analysis of the surface morphology and textile structure of the polyurethane Vascugraft arterial prosthesis using image and statistical analyses.

The surface morphology and textile structure of the Vascugraft polyurethane arterial prosthesis were investigated. Novel methods of image analysis and the presentation of statistical data were used to obtain quantitative results of the surface morphology of the non-woven microfibrous structure of prostheses of three different sizes. These techniques have identified apparent differences in the distributions of thickness and orientation of the microfibres between the internal and external surfaces and between the three prostheses investigated.

Biocompatible Materials↗

PubMed1994

In vitro exposure of a novel polyesterurethane graft to enzymes: a study of the biostability of the Vascugraft arterial prosthesis.

The biostability of the Vascugraft arterial prosthesis, a porous synthetic graft made by a novel spinning process from a unique poly(ester urethane) polymer, has been studied by means of an in vitro enzyme incubation technique. Samples of the Vascugraft were exposed to buffered solutions of collagenase and pancreatin, as well as the buffer solutions alone, for periods of up to 100 days at 37 +/- 1 degrees C. On removal and after cleaning, a number of different analytic methods, including X-ray photoelectron spectroscopy for chemical analysis (ESCA), attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), differential scanning calorimetry (DSC), size exclusion chromatography (SEC), scanning electron microscopy (SEM), interference microscopy, moisture content and contact angle measurements, were used to examine the changes in chemical structure and surface morphology of the samples. During incubation in both enzymes the molecular weight of the polyurethane appeared to decrease in the presence of enzyme but increase in the presence of buffer. Further microphase separation in the polyurethane material developed during incubation in buffer solutions. Such changes in microstructure were associated with increased surface hydrophilicity, increased moisture content and a significant improvement in the extent of order and preferred orientation of the hard segment domains within the fibres. In the sampling depth of about 5 nm, both enzymes decreased the carbonate group content at the surface of the prosthesis to as little as 40% of their original values. The results from ATR-FTIR and DSC demonstrated that this phenomenon was limited primarily to the soft segment phase. While the Vascugraft prosthesis did exhibit some limited chemical modifications on exposure to concentrated enzyme solutions, nevertheless such changes were confined to the surface layer of the polyurethane microfibres. The importance and significance of those results will be more adequately determined by in vivo investigation.

Blood Vessel Prosthesis↗

PubMed1994

Mechanical characterization of endoscopic surgical staples during an experimental hernia repair.

Recent developments in laparoscopic hernia repair techniques have led to the design of titanium staples. In a laparoscopic hernia repair, a polypropylene mesh is stapled over the direct and indirect hernia sites in the inguinal region. The effectiveness of these staples in holding the prosthetic mesh, and therefore providing adequate strength to the abdominal wall, has not been yet investigated. We have characterized the bursting strength (BS) of an experimental hernia mesh repair fixed with Prolene suture, which is used extensively for this procedure, and the BS of repairs fixed with two currently available staplers, the Endopath EMS endoscopic multifeed stapler and the Endo Hernia stapler. We first simulated abdominal wall hernias in 16 piglets by creating incisions on both sides of the abdomen of each animal. Each defect was then covered with a polypropylene mesh, which was fixed on one side with Prolene sutures and on the other side using either the Endopath EMS (Group 1) or the Endo Hernia stapler (Group 2). The abdominal tissue with the mesh covering the defect was then excised and the BS evaluated using an Instron machine. Since many mechanical characteristics contribute to the BS of a repair, we investigated these characteristics in vitro, including tensile properties of the staples and the prosthetic mesh as well as the suture-tearing resistance of the mesh. Polypropylene mesh exhibits the same elongation in the three directions, i.e. 0 degrees , 45 degrees and 90 degrees . This elongation was estimated at 136% (SD = 130).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1994

Effect of geometric taper on thrombosis in vascular prostheses: an ex vivo study.

A common method of assessing the thrombogenicity of prosthetic arterial grafts is to determine the amount of platelets and fibrin that accumulates on their surfaces. This study was designed to compare thrombus formation in cylindrical and tapered vascular grafts (angle of taper 0.5 deg) made from the same biomaterial. Turbulence was generated upstream of the grafts by means of a 75% axi-symmetric stenosis. In general, turbulence is dissipated by the effect of blood viscosity, whereas in a tapered graft, there is an additional reduction in the intensity of turbulence owing to the effect of converging flow through the taper. The aim of this study was to assess the effect of turbulence on thrombus formation in cylindrical and tapered grafts. After blood had circulated for 2 and 4 h through the cylindrical and tapered grafts, which formed part of two parallel ex vivo circuits, platelet deposition and fibrinogen uptake were measured by means of a radioisotope technique. Although the flow disturbances were less in the tapered grafts, no significant difference in platelet and fibrin deposition in the two types of graft was observed at 2 h. For the longer perfusion time, however, increased platelet and fibrin activity was recorded in the annular vortex region in the tapered grafts. In general, neither platelets nor fibrin accumulated in areas of high turbulence intensity.

Animals↗

PubMed1994

Mechanical properties of the rabbit cornea during wound healing after treatment with epidermal growth factor.

To determine whether epidermal growth factor (EGF) accelerates the healing of corneal tissue, we measured the tensile strength, ductility (total deformation at rupture) and toughness of 60 rabbit corneas with 7-mm perforating wounds after topical treatment with EGF or saline for 8, 13 or 23 days. The three mechanical properties were measured using corneal strips mounted on an Instron tensometer. A traction speed of 5 cm/min was chosen from speed-response curves for the three measures of interest. Since the values for eyes of a single rabbit were correlated, we used the data for one eye, selected at random, from each animal in the data analysis. EGF enhanced tensile strength (p = 0.003) and toughness (p = 0.03) of corneas without reducing ductility. The difference in tensile strength and toughness between EGF- and saline-treated corneas was more striking at 8 and 13 days than at 23 days. Histologic studies at 13 and 23 days supported these observations: at 13 days the healing process was more advanced in EGF-treated corneas, whereas at 23 days no histologic differences were noted. We conclude that EGF accelerates wound healing in rabbit corneas with perforating wounds without reducing ductility of the corneal tissue.

Administration, Topical↗

PubMed1993

Expanded polytetrafluoroethylene arterial prostheses in humans: histopathological study of 298 surgically excised grafts.

The expanded polytetrafluoroethylene vascular prosthesis is considered to be the best synthetic alternative for peripheral arterial reconstruction. Most studies on the healing characteristics of expanded polytetrafluoroethylene prostheses have been carried out on animals, and very few data are available on prosthesis implanted in humans long term. We implanted 298 expanded polytetrafluoroethylene grafts as arterial substitutes in humans. The mean duration of implantation was 523 d and the grafts were implanted mainly for infrainguinal or axillofemoral bypass. The cellular and collagen infiltration of the microporous expanded polytetrafluoroethylene structure was generally poor. Infiltration occurred mainly in the external region of the prosthetic wall and increased with the duration of implantation. The external reinforcement was not a major factor in limiting tissue infiltration. The luminal surfaces were covered with a thin, irregular layer of organized fibrin, interspersed with exposed expanded polytetrafluoroethylene areas. Mineral deposits were observed in five cases. Despite poor healing, the clinical performance of expanded polytetrafluoroethylene vascular prostheses is relatively good. Since the chief advantage of this material is good mechanical stability in vivo, any modifications of the graft to improve healing characteristics or thrombogenic properties should not be made at the expense of stability in vivo.

Adult↗

PubMed1993

Expanded polytetrafluoroethylene arterial prostheses in humans: chemical analysis of 79 explanted specimens.

The expanded polytetrafluoroethylene (ePTFE) vascular prostheses are widely used as small and medium diameter blood conduits when an autologous venous material is not available or is not suitable. The long-term performance of a prosthesis is dependent on several factors, including its healing characteristics and its stability in vivo. This study was undertaken to assess whether chemical degradation of ePTFE occurs when such arterial substitutes are implanted in humans. Seventy-nine ePTFE grafts excised for complications were analysed using the following techniques: measurement of the contact angle (theta), electron spectroscopy for chemical analysis (ESCA or XPS), Fourier transform infra-red spectroscopy (FTIR) and differential scanning calorimetry (DSC). The results were compared with those obtained from virgin ePTFE and virgin ePTFE washed prostheses. The measurement of the contact angle (theta) permits the comparison of the level of hydrophobicity of material after in vivo residency. The contact angles of explanted ePTFE grafts are greater than those of virgin ones but remain close to those of washed virgin prostheses. The ESCA method allowed investigation of the chemical changes which occur on the surface of ePTFE prostheses after implantation because of the low penetration of the X-ray (about 50 A). This study did not reveal any chemical degradation of the ePTFE with time of implantation for periods up to 6.5 yr. Changes in the surface composition were probably related to lipid and/or protein uptake. The FTIR spectroscopy provides information about the chemical composition of material. Compared with the virgin ePTFE prostheses, the FTIR spectra of explanted prostheses showed specific bands which are characteristic of lipid and/or protein absorptions. The bulk properties of ePTFE studied by DSC did not show any significant changes with time of implantation. It is concluded that ePTFE grafts remain stable in vivo for periods up to 6.5 yr.

Biocompatible Materials↗